Updating results…
What is RTL 1000?
RTL1000 is a new agent that has not been previously tested in humans. It is thought that RTL may specifically control the abnormal immune response or attack against the insulation on the nerves that occurs in multiple sclerosis. It is currently in clinical trials.
Reported Stop Reasons
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Course of treatment ended | 1 |  |
Reported Duration See details about how long patients take this treatment ▼
Stopped Using RTL 1000
A bar graph
| 0-1 month | 1-3 months | 3-6 months | 6 months-1year | 1-2 years | 2 years or more |
|---|---|---|---|---|---|
|
0
|
0
|
0
|
0
|
0
|